|
1
|
Ostrom QT, Gittleman H, Xu J, Kromer C,
Wolinsky Y, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical
report: Primary brain and other central nervous system tumors
diagnosed in the united states in 2009–2013. Neuro Oncol. 18 (Suppl
5):v1–v75. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reifenberger G, Wirsching HG,
Knobbe-Thomsen CB and Weller M: Advances in the molecular genetics
of gliomas-implications for classification and therapy. Nat Rev
Clin Oncol. 14:434–452. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gravendeel LA, Kouwenhoven MC, Gevaert O,
de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB,
Kloosterhof NK, et al: Intrinsic gene expression profiles of
gliomas are a better predictor of survival than histology. Cancer
Res. 69:9065–9072. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Verhaak RGW, Hoadley KA, Purdom E, Wang V,
Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al:
Integrated genomic analysis identifies clinically relevant subtypes
of glioblastoma characterized by abnormalities in PDGFRA, IDH1,
EGFR, and NF1. Cancer Cell. 17:98–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hessels D and Schalken JA: The use of PCA3
in the diagnosis of prostate cancer. Nat Rev Urol. 6:255–261. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reon BJ, Anaya J, Zhang Y, Mandell J,
Purow B, Abounader R and Dutta A: Expression of lncRNAs in
low-grade gliomas and glioblastoma multiforme: An in silico
analysis. PLoS Med. 13:e10021922016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang XQ and Leung GK: Long non-coding
RNAs in glioma: Functional roles and clinical perspectives.
Neurochem Int. 77:78–85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang X, Kiang KM, Zhang GP and Leung GK:
Long non-coding RNAs dysregulation and function in glioblastoma
stem cells. Noncoding RNA. 1:69–86. 2015.PubMed/NCBI
|
|
13
|
Madhavan S, Zenklusen JC, Kotliarov Y,
Sahni H, Fine HA and Buetow K: Rembrandt: Helping personalized
medicine become a reality through integrative translational
research. Mol Cancer Res. 7:157–167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun LX, Hui AM, Su Q, Vortmeyer A,
Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey
R, et al: Neuronal and glioma-derived stem cell factor induces
angiogenesis within the brain. Cancer Cell. 9:287–300. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murat A, Migliavacca E, Gorlia T, Lambiv
WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven
MC, et al: Stem cell-related ‘self-renewal’ signature and high
epidermal growth factor receptor expression associated with
resistance to concomitant chemoradiotherapy in glioblastoma. J Clin
Oncol. 26:3015–3024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dai M, Wang P, Boyd AD, Kostov G, Athey B,
Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, et al: Evolving
gene/transcript definitions significantly alter the interpretation
of GeneChip data. Nucleic Acids Res. 33:e1752005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheadle C, Vawter MP, Freed WJ and Becker
KG: Analysis of microarray data using z score transformation. J Mol
Diagn. 5:73–81. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hubbard T, Barker D, Birney E, Cameron G,
Chen Y, Clark L, Cox T, Cuff J, Curwen V, Down T, et al: The
Ensembl genome database project. Nucleic Acids Res. 30:38–41. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simon R, Lam A, Li MC, Ngan M, Menenzes S
and Zhao Y: Analysis of gene expression data using BRB-ArrayTools.
Cancer Inform. 3:11–17. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lossos IS, Czerwinski DK, Alizadeh AA,
Wechser MA, Tibshirani R, Botstein D and Levy R: Prediction of
survival in diffuse large-B-cell lymphoma based on the expression
of six genes. N Engl J Med. 350:1828–1837. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang XQ, Sun S, Lam KF, Kiang KM, Pu JK,
Ho AS, Lui WM, Fung CF, Wong TS and Leung GK: A long non-coding RNA
signature in glioblastoma multiforme predicts survival. Neurobiol
Dis. 58:123–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Heagerty PJ, Lumley T and Pepe MS:
Time-dependent ROC curves for censored survival data and a
diagnostic marker. Biometrics. 56:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiao S, Wang R, Wu X, Liu W and Ma S: The
long noncoding RNA TP73-AS1 interacted with miR-124 to modulate
glioma growth by targeting inhibitor of apoptosis-stimulating
protein of p53. DNA Cell Biol. 37:117–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang R, Jin H and Lou F: The long
non-coding RNA TP73-AS1 interacted with miR-142 to modulate brain
glioma growth through HMGB1/RAGE pathway. J Cell Biochem.
119:3007–3016. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang JB, Liu FH, Chen JH, Ge HT, Mu LY,
Bao HB and Lin ZG: Identifying survival-associated modules from the
dysregulated triplet network in glioblastoma multiforme. J Cancer
Res Clin Oncol. 143:661–671. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du Z, Fei T, Verhaak RG, Su Z, Zhang Y,
Brown M, Chen Y and Liu XS: Integrative genomic analyses reveal
clinically relevant long noncoding RNAs in human cancer. Nat Struct
Mol Biol. 20:908–913. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lagarde J, Uszczynska-Ratajczak B,
Carbonell S, Pérez-Lluch S, Abad A, Davis C, Gingeras TR, Frankish
A, Harrow J, Guigo R and Johnson R: High-throughput annotation of
full-length long noncoding RNAs with capture long-read sequencing.
Nat Genet. 49:1731–1740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dang L, Yen K and Attar EC: IDH mutations
in cancer and progress toward development of targeted therapeutics.
Ann Oncol. 27:599–608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Turcan S, Rohle D, Goenka A, Walsh LA,
Fang F, Yilmaz E, Campos C, Fabius AW, Lu C, Ward PS, et al: IDH1
mutation is sufficient to establish the glioma hypermethylator
phenotype. Nature. 483:479–483. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li S, Huang Y, Huang Y, Fu Y, Tang D, Kang
R, Zhou R and Fan XG: The long non-coding RNA TP73-AS1 modulates
HCC cell proliferation through miR-200a-dependent HMGB1/RAGE
regulation. J Exp Clin Cancer Res. 36:512017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yao J, Xu F, Zhang D, Yi W, Chen X, Chen G
and Zhou E: TP73-AS1 promotes breast cancer cell proliferation
through miR-200a-mediated TFAM inhibition. J Cell Biochem.
119:680–690. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li W, Li H, Zhang L, Hu M, Li F, Deng J,
An M, Wu S, Ma R, Lu J and Zhou Y: Long non-coding RNA LINC00672
contributes to p53 protein-mediated gene suppression and promotes
endometrial cancer chemosensitivity. J Biol Chem. 292:5801–5813.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Akiel M, Guo C, Li X, Rajasekaran D,
Mendoza RG, Robertson CL, Jariwala N, Yuan F, Subler MA, Windle J,
et al: IGFBP7 deletion promotes hepatocellular carcinoma. Cancer
Res. 77:4014–4025. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jhuraney A, Woods NT, Wright G, Rix L,
Kinose F, Kroeger JL, Remily-Wood E, Cress WD, Koomen JM, Brantley
SG, et al: PAXIP1 potentiates the combination of WEE1 inhibitor
AZD1775 and platinum agents in lung cancer. Mol Cancer Ther.
15:1669–1681. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Beltran M, Puig I, Peña C, García JM,
Alvarez AB, Peña R, Bonilla F and de Herreros AG: A natural
antisense transcript regulates Zeb2/Sip1 gene expression during
snail1-induced epithelial-mesenchymal transition. Genes Dev.
22:756–769. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Suzuki K and Matsubara H: Recent advances
in p53 research and cancer treatment. J Biomed Biotechnol.
2011:9783122011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kahlert UD, Nikkhah G and Maciaczyk J:
Epithelial-to-mesenchymal(-like) transition as a relevant molecular
event in malignant gliomas. Cancer Lett. 331:131–138. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pećina-Šlaus N, Kafka A, Varošanec AM,
Marković L, Krsnik Ž, Njirić N and Mrak G: Expression patterns of
Wnt signaling component, secreted frizzled-related protein 3 in
astrocytoma and glioblastoma. Mol Med Rep. 13:4245–4251. 2016.
View Article : Google Scholar : PubMed/NCBI
|
